Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Marina A. Zemskova"'
Autor:
Evgeny A. Zemskov, Christine M. Gross, Saurabh Aggarwal, Marina A. Zemskova, Xiaomin Wu, Chenxin Gu, Ting Wang, Haiyang Tang, Stephen M. Black
Publikováno v:
Frontiers in Physiology, Vol 13 (2022)
In acute lung injury (ALI), the NF-κB-mediated downregulation of Sox18 gene expression leads to the disruption of the pulmonary endothelial barrier. Previous studies have suggested that the action of NF-κB as a transcriptional repressor also requir
Externí odkaz:
https://doaj.org/article/872767de9a5d4a08b5affe0f28d47853
Autor:
Alexey S. Kazakov, Marina Y. Zemskova, Gleb K. Rystsov, Alisa A. Vologzhannikova, Evgenia I. Deryusheva, Victoria A. Rastrygina, Andrey S. Sokolov, Maria E. Permyakova, Ekaterina A. Litus, Vladimir N. Uversky, Eugene A. Permyakov, Sergei E. Permyakov
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 24; Pages: 15956
Tumor necrosis factor (TNF) inhibitors (anti-TNFs) represent a cornerstone of the treatment of various immune-mediated inflammatory diseases and are among the most commercially successful therapeutic agents. Knowledge of TNF binding partners is criti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9234c2b9075f8e441d5382a9bc5ba0b0
Autor:
Alexey S. Kazakov, Marina Y. Zemskova, Gleb K. Rystsov, Alisa A. Vologzhannikova, Evgenia I. Deryusheva, Victoria A. Rastrygina, Andrey S. Sokolov, Maria E. Permyakova, Ekaterina A. Litus, Vladimir N. Uversky, Eugene A. Permyakov, Sergei E. Permyakov
Tumor necrosis factor (TNF) inhibitors (anti-TNFs) represent a cornerstone of the treatment of various immune-mediated inflammatory diseases and are among the most commercially successful therapeutic agents. Knowledge of TNF binding partners is criti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29a7ddc574a054bb2d57d1b2bf00a122
Autor:
Maki Niihori, Natalie K. Barker, Olga Rafikova, Mathews Valuparampil Varghese, Cody A. Eccles, Ruslan Rafikov, Lawrence J. Mandarino, Marina A. Zemskova, Paul R. Langlais, Moulun Luo, Joel James
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology
Supplemental Digital Content is available in the text.
Objective: NFU1 is a mitochondrial iron-sulfur scaffold protein, involved in iron-sulfur assembly and transfer to complex II and LAS (lipoic acid synthase). Patients with the point mutation
Objective: NFU1 is a mitochondrial iron-sulfur scaffold protein, involved in iron-sulfur assembly and transfer to complex II and LAS (lipoic acid synthase). Patients with the point mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eacc0854ea99c17175f67aed8c1a1f4e
https://doi.org/10.1161/atvbaha.120.314655
https://doi.org/10.1161/atvbaha.120.314655
Autor:
Marina A. Zemskova, Ruslan Rafikov, Anup Srivastava, Mathews Valuparampil Varghese, Cody A. Eccles, Joel James, Olga Rafikova
Publikováno v:
Blood
Several studies demonstrate that hemolysis and free heme in circulation cause endothelial barrier dysfunction and are associated with severe pathological conditions such as acute respiratory distress syndrome, acute chest syndrome, and sepsis. Howeve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::377d6180c9e33322b5d7259ad26ed669
https://doi.org/10.1182/blood.2019003986
https://doi.org/10.1182/blood.2019003986
Autor:
Anna A. Stepanova, Alexander Galkin, Maki Niihori, Sergey Kurdyukov, Mathews Valuparampil Varghese, Olga Rafikova, Marina A. Zemskova, Cody A. Eccles, Ruslan Rafikov
Publikováno v:
American Journal of Respiratory Cell and Molecular Biology. 62:231-242
NFU1 is a mitochondrial protein that is involved in the biosynthesis of iron-sulfur clusters, and its genetic modification is associated with disorders of mitochondrial energy metabolism. Patients ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d87f6adb0b5a6106db31296e5c552ca5
https://doi.org/10.1165/rcmb.2019-0065oc
https://doi.org/10.1165/rcmb.2019-0065oc
Autor:
Marina A. Zemskova, Maki Niihori, Paul R. Langlais, Nolan McClain, Ruslan Rafikov, Matthew L. McBride, Olga Rafikova, Sergey Kurdyukov
Publikováno v:
American Journal of Physiology-Lung Cellular and Molecular Physiology. 316:L428-L444
Pulmonary arterial hypertension (PAH) is a lethal disease characterized by progressive pulmonary vascular remodeling. The receptor for advanced glycation end products (RAGE) plays an important role in PAH by promoting proliferation of pulmonary vascu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::494d466d65f298d750994b11298904d5
https://doi.org/10.1152/ajplung.00393.2018
https://doi.org/10.1152/ajplung.00393.2018
Publikováno v:
Circulation. 142
Introduction: Several studies confirm that free heme in circulation due to hemolysis causes endothelial barrier dysfunction. We recently demonstrated that hemolysis-induced vascular leakage with barrier dysfunction was a contributory factor to the de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea86ee83eaaca7a1dd1d8554befafbe1
https://doi.org/10.1161/circ.142.suppl_3.17211
https://doi.org/10.1161/circ.142.suppl_3.17211
Autor:
Olga Rafikova, Marina A. Zemskova, Mathews Valuparampil Varghese, Nolan McClain, Maki Niihori, Ruslan Rafikov, Joel James
Publikováno v:
Hypertension
Damage-associated molecular patterns, such as HMGB1 (high mobility group box 1), play a well-recognized role in the development of pulmonary arterial hypertension (PAH), a progressive fatal disease of the pulmonary vasculature. However, the contribut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb908d1ab382055c3d1a4f15940f01c1
https://pubmed.ncbi.nlm.nih.gov/33012199
https://pubmed.ncbi.nlm.nih.gov/33012199
Autor:
Marina Y. Zemskova, Maria V. Marinets, Andrey V. Sivkov, Julia V. Pavlova, Andrey N. Shibaev, Konstantin S. Sorokin
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2021)
Frontiers in Oncology, Vol 10 (2021)
Prostate cancer (PCa) diagnosis based on patient urine analysis provides non-invasive and promising method as compared to biopsy and a prostate-specific antigen (PSA) test. This study was conceived to investigate whether Integrin alpha V (ITGAV) prot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::215445ff1e5d2207bf76a2525ee32b62
https://pubmed.ncbi.nlm.nih.gov/33791193
https://pubmed.ncbi.nlm.nih.gov/33791193